Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeWages, Salaries and Other
Others
Ratios

Design Therapeutics (DSGN) Revenue (2020)

Design Therapeutics' Revenue history spans 1 years, with the latest figure at $33000.0 for Q4 2020.

  • For Q4 2020, Revenue changed N/A year-over-year to $33000.0; the TTM value through Sep 2021 reached $33000.0, changed N/A, while the annual FY2025 figure was $9.7 million, 24.38% down from the prior year.
  • Revenue for Q4 2020 was $33000.0 at Design Therapeutics, up from $20000.0 in the prior quarter.
  • Across five years, Revenue topped out at $142000.0 in Q1 2020 and bottomed at $20000.0 in Q3 2020.